377 related articles for article (PubMed ID: 2108851)
1. Thrombolytic therapy in acute myocardial infarction.
Rutherford JD; Braunwald E
Chest; 1990 Apr; 97(4 Suppl):136S-145S. PubMed ID: 2108851
[TBL] [Abstract][Full Text] [Related]
2. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
3. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
4. New developments in thrombolytic therapy.
Collen DC; Gold HK
Thromb Res Suppl; 1990; 10():105-31. PubMed ID: 2180114
[TBL] [Abstract][Full Text] [Related]
5. [Thrombolytic drugs in acute myocardial infarct].
Ambrosioni E; Degli Esposti D
Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796
[TBL] [Abstract][Full Text] [Related]
6. New developments in thrombolytic therapy.
Collen D; Gold HK
Verh K Acad Geneeskd Belg; 1989; 51(3):191-228; discussion 229. PubMed ID: 2686261
[TBL] [Abstract][Full Text] [Related]
7. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
[TBL] [Abstract][Full Text] [Related]
8. Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
Hackworthy RA; Sorensen SG; Menlove RL; Anderson JL
Drugs; 1987; 33 Suppl 3():198-208. PubMed ID: 3315592
[TBL] [Abstract][Full Text] [Related]
9. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC).
Johnson ES; Cregeen RJ
Drugs; 1987; 33 Suppl 3():298-311. PubMed ID: 3315612
[TBL] [Abstract][Full Text] [Related]
10. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
Crabbe SJ; Grimm AM; Hopkins LE
Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
[TBL] [Abstract][Full Text] [Related]
11. Intravenous thrombolytic therapy in myocardial infarction: an analytical review.
Shammas NW; Zeitler R; Fitzpatrick P
Clin Cardiol; 1993 Apr; 16(4):283-92. PubMed ID: 8458108
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic therapy.
Collen D; Stump DC; Gold HK
Annu Rev Med; 1988; 39():405-23. PubMed ID: 3130773
[TBL] [Abstract][Full Text] [Related]
13. Coronary thrombolysis with clot-selective plasminogen activators.
Collen D; Bounameaux H
Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
[TBL] [Abstract][Full Text] [Related]
14. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
[TBL] [Abstract][Full Text] [Related]
15. Intravenous fibrinolytic therapy of acute myocardial infarction: new perspectives from plasminogen activators?
Kasper W; Meinertz T; Just H
Klin Wochenschr; 1986 Apr; 64(7):301-6. PubMed ID: 3086619
[TBL] [Abstract][Full Text] [Related]
16. Is survival in acute myocardial infarction related to thrombolytic efficacy or the open-artery hypothesis? A controversy to be investigated with GUSTO.
Bates ER
Chest; 1992 Apr; 101(4 Suppl):140S-150S. PubMed ID: 1555479
[TBL] [Abstract][Full Text] [Related]
17. [t-PA in thrombolytic therapy of acute myocardial infarct].
Rutsch W; Schmutzler H
Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of clinical efficacy of thrombolytic drugs in patients with acute myocardial infarction].
López-Sendón JL
Rev Esp Cardiol; 1992; 45 Suppl 2():9-20. PubMed ID: 1475514
[TBL] [Abstract][Full Text] [Related]
19. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.
Lancet; 1992 Mar; 339(8796):753-70. PubMed ID: 1347801
[TBL] [Abstract][Full Text] [Related]
20. Effect of reperfusion on electrocardiographic and enzymatic infarct size: results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarction.
Hackworthy RA; Sorensen SG; Fitzpatrick PG; Barry WH; Menlove RL; Rothbard RL; Anderson JL
Am Heart J; 1988 Oct; 116(4):903-14. PubMed ID: 3051985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
